TransEnterix (NYSE:TRXC) said yesterday that it agreed to amend a previously announced sale agreement with Great Belief International for the AutoLap system. On July 10, Research Triangle Park, N.C.-based TransEnterix announced that it dealt the AutoLap assets it had acquired in October 2018 along with Medical Surgery Technologies to Great Belief International for $47 million. This week, TransEnterix entered into an amended and restated system sale agreement to restructure the sale of the AutoLap assets. The AutoLap system is an image-based scope positioning system for laparoscopic procedures. Under the agreement, TransEnterix sold the AutoLap system and its related assets to GBI for $17 million and will enter into a cross-license agreement with GBI to retain rights to use AutoLap-related intellectual property, as well as to non-exclusively license additional intellectual property to GBI. The amendment removes the obligation for GBI to make a $30 million equity investment in TransEnterix, which was part of the initial agreement made in July, according to an SEC filing. Additionally, TransEnterix said it enlisted J.P Morgan to evaluate strategic alternatives as it shifts its oper...